Skip Navigation



Hum. Reprod. Advance Access published online on July 7, 2009
Human Reproduction, doi:10.1093/humrep/dep234
This Article
Right arrow Full Text
Right arrow Full Text (PDF )
Right arrow All Versions of this Article:
24/10/2477    most recent
dep234v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mateizel, I.
Right arrow Articles by Sermon, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mateizel, I.
Right arrow Articles by Sermon, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically

I. Mateizel1,4, C. Spits1, A. Verloes2, A. Mertzanidou1, I. Liebaers1,3 and K. Sermon1

1 Department of Embryology and Genetics, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium 2 Department of Hematology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium 3 Centre for Medical Genetics, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium

4 Correspondence address. Tel: +32-2-477-66-73; Fax: +32-2-477-66-92; E-mail: ileana.mateizel{at}uzbrussel.be

BACKGROUND: The presence of chromosomal abnormalities could have a negative impact for human embryonic stem cell (hESC) applications both in regenerative medicine and in research. A biomarker that allows the identification of chromosomal abnormalities induced in hESC in culture before they take over the culture would represent an important tool for defining optimal culture conditions for hESC. Here we investigate the expression of CD30, reported to be a biomarker of hESCs with abnormal karyotype, in undifferentiated and spontaneously differentiated hESC.

METHODS AND RESULTS: hESC were derived and cultured on mouse fibroblasts in KO–SR containing medium (serum free media) and passaged mechanically. Our results based on analysis at mRNA (RT–PCR) and protein (fluorescence-activated cell sorting and immunocytochemistry) level show that CD30 is expressed in undifferentiated hESC, even at very early passages, without any correlation with the presence of chromosomal anomalies. We also show that the expression of CD30 is rapidly lost during early spontaneous differentiation of hESC.

CONCLUSION: We conclude that CD30 expression in hESC cultures is probably a consequence of culture conditions, and that KO–SR may play a role. In addition, the expression of so-called ‘stemness’ markers does not change in undifferentiated hESC during long-term culture or when cells acquire chromosomal abnormalities.

Key words: human embryonic stem cells/CD30/chromosomal abnormalities/long-term culture

Submitted on April 29, 2009; resubmitted on May 26, 2009; accepted on June 5, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.